Developer of cloud-based healthcare software designed to help accelerate the development of new, life-saving therapies.
Developer of cloud-based healthcare software designed to help accelerate the development of new, life-saving therapies.
Enterprise Systems (Healthcare)📍 Boston, MAFounded 2012
Current Valuation
$4.8B
as of 2022-Q1
UNICORN
QL Price
$4.8B
0% vs last round
QuantLogix's current estimate for Reify Health, published 2026-09-27 — in line with the last disclosed round of $4.8B (2022-Q1).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$4.8B
2022-Q1
weight 0.04
How this price has held up
No round has priced for Reify Health since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Reify Health, 2026-09-27 (bce9a8207911d0e8).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Reify Health going public?
No. Reify Health is private and has not filed to go public. There is no S-1 on file.
What is Reify Health's valuation in 2026?
Reify Health is valued at $4.8B as of 2022-Q1, set by its Series D ($216.89M, Jan 2022). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Reify Health filed an S-1?
No public S-1 is on file for Reify Health.
How much has Reify Health raised?
Reify Health has raised $476.57M in total, most recently a Series D of $216.89M in Jan 2022.
Is Reify Health publicly traded — can you buy Reify Health stock?
No. Reify Health is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Reify Health on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2012
HQ
Boston, MA
Employees
224
Total Raised
$476.57M
Last Round
Series D — $216.89M (Jan 2022)
IPO Status
private
Fundraising Status
Series D · $216.89M · 4y 8mo ago
privateTotal raised $476.57M
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series D
$216.89M
Jan 2022
—
$4.8B
Talent Signal
Hiring trend
▼ Hiring downtrend
-14% vs 2026-08
Open roles
6
via greenhouse
Product-build share
50%
engineering, research, product, design
Trajectory
tightening
product-led hiring — 50% of open roles build product; the rest are go-to-market and G&A.
Open roles trending down; no tracked executive churn.
Counted from Reify Health's live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
SoftwareClinical TrialsHealth CareMobile
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q1. Refreshed quarterly.